SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 57 filers reported holding SIO GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $392 | – | 902 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 902 | -1.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 916 | -69.1% | 0.00% | – |
| Q1 2022 | $2,000 | -66.7% | 2,964 | -37.8% | 0.00% | – |
| Q4 2021 | $6,000 | -95.0% | 4,764 | -91.5% | 0.00% | – |
| Q3 2021 | $121,000 | -48.3% | 55,741 | -35.1% | 0.00% | – |
| Q2 2021 | $234,000 | -22.0% | 85,842 | -25.3% | 0.00% | – |
| Q1 2021 | $300,000 | – | 114,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,104,000 | $1,424,000 | 1.31% |
| Prosight Management, LP | 802,180 | $1,035,000 | 0.62% |
| Privium Fund Management B.V. | 1,806,542 | $2,367,000 | 0.47% |
| Rubric Capital Management LP | 3,000,000 | $3,870,000 | 0.18% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $239,000 | 0.17% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $7,629,000 | 0.15% |
| APOGEM CAPITAL LLC | 60,245 | $78,000 | 0.05% |
| Clearline Capital LP | 218,506 | $282,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 166,806 | $215,000 | 0.03% |
| Hudson Bay Capital Management LP | 1,800,000 | $2,322,000 | 0.02% |